PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Saturday, May 31
    Trending
    • Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%
    • Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
    • IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25
    • Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers
    • WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law
    • Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth
    • Profin Range of Aluminium Profiles by Hafele
    • Business Outline Announces the Business Elite Award | Recognising Exceptional Business Leaders and Companies
    Submit News
    Twitter LinkedIn Instagram
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»PNN News

    Dr. Sridhar PS on the remarkable success of CyberKnife in combating brain tumors

    Devv JaniDevv JaniUpdated:07/11/2023 PNN News 4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), November 7: The CyberKnife System scores an edge over brain tumor surgery which has been the mainstay of treating brain tumours but comes with a share of complications such as internal bleeding, cerebrospinal fluid leakage, recurrence, blood clots and many more.

    Radiation therapy is one of the options to treat cancer. It is essential to accurately deliver radiation to the tumor to kill the cancer cells and minimize its dose to the nearby healthy tissues, which Cyberknife is capable of. Similarly, it ensures a better quality of life for the patients during and after the completion of treatment, as this treatment potentially reduces the risk of side effects.

    Prof. Dr. Sridhar Papaiah Susheela, leading radiation oncologist in India, states, ‘Treating brain tumor through CyberKnife has delivered excellent outcomes while minimizing the potential complications and side effects likely to emerge from surgical procedures’.

    Stereotactic radiosurgery (SRS) treatment is a non-surgical and non-invasive procedure that delivers radiation with sub-millimetre accuracy without affecting the tumour’s surrounding areas. The CyberKnife System in treating brain tumor can be completed in fewer sessions, which can be scheduled in two to three weeks. With the advancements of cyberknife treatment in India, there are hardly any side effects of this treatment.

    The additional advantages of the CyberKnife System include reasonable cancer control, less incidence of cognitive side effects, and no interruption of chemotherapy cycles or immunotherapy treatments. The CyberKnife can be administered to patients previously treated with stereostatic radiation therapy. Additionally, the patients can continue their regular activity during treatment as it is a non-invasive and non-surgical treatment.

    There is ample evidence that CyberKnife treatment technology is reliable and safe, as it has been used for over two decades. Most radiation oncologists have successfully treated various brain tumor conditions, such as malignant and benign primary tumors, trigeminal neuralgia, brain metastases, arteriovenous malformations- AVMs, acoustic neuromas and other related conditions. Moreover, CyberKnife can also treat complicated neurosurgical cases without impairing motor, vision, and audio functioning. Hence, seeking a highly experienced radiation oncologist in India to perform the CyberKnife SRS treatment is essential. 

     Dr. Sridhar P S elaborates on the critical features of Cyberknife technology, which makes it the most preferred treatment option to deliver radiation to hard-to-reach areas. The Cyberknife has a linear accelerator (linac) directly mounted on a robot through which the oncologist can deliver high-energy x-rays or photons.

    The robot can move and bend in various angles and positions around the patient to deliver radiation doses to the tumour’s exact location while minimizing the radiation delivered in nearby healthy areas. The motion synchronization feature of Cyberknife treatment is yet another critical feature. Through this machine, the radiation oncologist can ensure that the radiation is precisely and accurately delivered despite the normal body movement or movement of the tumor.

    It is normal to expect the patient to move with regards to breathing, bladder movement, and gas, leading to movement of the tumor by a few millimetres or so, which can alter the precise delivery of radiation and also affect the healthy tissues in the surrounding areas and reduce the side effects of radiation as well.

    Hence, precision delivery and motion synchronization features of the Cyberknife treatment help radiation oncologists treat cancer patients for better outcomes. As stated by Dr. Sridhar P S, “I consider the Cyberknife treatment approach one of the most befitting medical innovations of our times. The unparalleled precision and motion synchronization possible through Cyberknife has minimized invasive approach and maximized the outcomes, thus giving renewed patient’s hopes to live a normal and healthy life.”

    About Dr. Sridhar PS

    Dr. Sridhar P S is a leading radiation oncologist in India with over 19 years of experience. He performs CyberKnife treatment for the whole body. He has successfully treated numerous cases of cancers, including neurological and benign tumors. He is an expert in oncology imaging, 3DCRT, IMRT, IGRT, SBRT, TomoTherapy forms of high-precision radiotherapy and chemoradiotherapy. Also, he is an expert in genomics, radiogenomics, hepatobiliary, prostate, CNS, pancreatic cancer and so on. 

    Contact Dr. Sridhar P S:

    • HCG – The Specialist in Cancer Care, Tower -4, Room No. 219, 9/1, Kalinga Rao Rd, Sampangi Rama Nagar, Bengaluru, Karnataka. Landmark: Near SCMI, Bangalore
    • HCG ICS Khubchandani Cancer Centre, 31, Queens Barracks, LadyRatanTata Building, MaharshiKarve Rd, Cooperage, Mumbai, Maharashtra 400021
    • HCG CCK Cancer Centre, Shivachi Road, Parklands, Nairobi, Kenya

    Phone Numbers: +91 90084 82284 / +91 98865 54972

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Devv Jani

    Keep Reading

    Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%

    Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

    IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25

    Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers

    WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth

    Recent Posts
    • Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%
    • Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
    • IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25
    • Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers
    • WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    Aayush Wellness’s FY25 Revenue Rockets 8,645%, Net Profit Soars 489%

    31/05/2025

    Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

    31/05/2025

    IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25

    31/05/2025

    Deliure Unveils Exclusive Tres Leches Cakes for Mumbai’s Dessert Lovers

    30/05/2025

    WARF Invites Colleges to Join India’s Top 2025 Ranking Survey for Engineering, Medical, MBA and Law

    30/05/2025

    Maximus International’s Momentum Continues: Strategic Investments Fuel 26 Percent EBITDA Growth

    30/05/2025
    Facebook Twitter Pinterest Vimeo WhatsApp TikTok Instagram

    MENU

    • Home
    • Business
    • Education
    • Home
    • Business
    • Education
    • National
    • Lifestyle

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2025 PNN Digital. Designed by Primex Media Services.
    • About Us
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.